Asian journal of urology,
Journal Year:
2020,
Volume and Issue:
8(2), P. 144 - 154
Published: May 30, 2020
The
development
of
germ
cell
tumors
(GCTs)
is
a
unique
pathogenesis
occurring
at
an
early
developmental
stage
during
specification,
migration
or
colonization
primordial
cells
(PGCs)
in
the
genital
ridge.
Since
driver
mutations
could
not
be
identified
so
far,
involvement
epigenetic
machinery
seems
to
play
crucial
role.
Currently,
it
investigated
whether
modifications
between
omnipotent
two-cell
and
pluripotent
implanting
PGCs
might
result
disturbances
eventually
leading
GCTs.
Although
progress
understanding
mechanisms
PGC
ongoing,
little
known
about
complete
picture
its
GCT
eventual
classification
into
clinical
subtypes.
This
review
will
shed
light
current
knowledge
complex
molecular
contribution
GCTs
by
emphasizing
on
stages
until
arrival
late
gonads.
We
questioned
how
misguided
migrating
and/or
colonizing
develop
either
type
I
II
Additionally,
we
asked
pluripotency
can
regulated
which
changes
contribute
pathogenesis.
propose
that
SOX2
SOX17
determine
embryonic
stem
cell-like
(embryonal
carcinoma)
PGC-like
fate
(seminoma).
Finally,
suggest
factors
secreted
microenvironment,
i.e.
BMPs
BMP
inhibiting
molecules,
dictate
decision
neoplasia
situ
(into
seminoma
embryonal
seminomas
carcinoma
extraembryonic
lineage),
indicating
important
role
microenvironment
plasticity.
Cancer Discovery,
Journal Year:
2021,
Volume and Issue:
12(2), P. 331 - 355
Published: Dec. 17, 2021
Abstract
Pediatric
tumors
are
uncommon,
yet
the
leading
cause
of
cancer-related
death
in
childhood.
Tumor
types,
molecular
characteristics,
and
pathogenesis
unique,
often
originating
from
a
single
genetic
driver
event.
The
specific
diagnostic
challenges
childhood
led
to
development
first
World
Health
Organization
(WHO)
Classification
Tumors.
classification
is
rooted
multilayered
approach,
incorporating
morphology,
IHC,
characteristics.
volume
organized
according
organ
sites
provides
single,
state-of-the-art
compendium
pediatric
tumor
types.
A
special
emphasis
was
placed
on
“blastomas,”
which
variably
recapitulate
morphologic
maturation
organs
they
originate.
Significance:
In
this
review,
we
briefly
summarize
main
features
updates
each
chapter
inaugural
WHO
Tumors,
including
its
rapid
transition
mostly
microscopic
into
molecularly
driven
systematically
taking
recent
discoveries
genomics
account.
Molecular Cancer,
Journal Year:
2023,
Volume and Issue:
22(1)
Published: Nov. 28, 2023
The
advent
of
iPSCs
has
brought
about
a
significant
transformation
in
stem
cell
research,
opening
up
promising
avenues
for
advancing
cancer
treatment.
formation
is
multifaceted
process
influenced
by
genetic,
epigenetic,
and
environmental
factors.
offer
distinctive
platform
investigating
the
origin
cancer,
paving
way
novel
approaches
to
treatment,
drug
testing,
tailored
medical
interventions.
This
review
article
will
provide
an
overview
science
behind
iPSCs,
current
limitations
challenges
iPSC-based
therapy,
ethical
social
implications,
comparative
analysis
with
other
types
also
discuss
applications
tumorigenesis,
future
tumorigenesis
highlight
successful
case
studies
utilizing
research.
conclusion
summarize
advancements
made
research
importance
continued
investment
iPSC
unlock
full
potential
these
cells.
Neuro-Oncology,
Journal Year:
2021,
Volume and Issue:
24(4), P. 516 - 527
Published: Oct. 28, 2021
The
incidence
of
intracranial
germ
cell
tumors
(iGCT)
is
much
lower
in
European
and
North
American
(E&NA)
than
Asian
population.
However,
E&NA
cooperative
groups
have
simultaneously
developed
with
success
treatment
strategies
specific
attention
paid
to
long-term
sequelae.
Neurological
sequelae
may
be
reduced
by
establishing
a
diagnosis
an
endoscopic
biopsy
and/or
cerebrospinal
fluid
(CSF)
serum
analysis,
deferring
the
need
perform
radical
surgery.
Depending
on
markers
histological
characteristics,
patients
are
treated
as
either
germinoma
or
non-germinomatous
(NGGCT).
Metastatic
disease
defined
positive
CSF
cytology
distant
drops
craniospinal
MRI.
combination
surgery
chemotherapy
radiation
therapy
tailored
according
grouping
staging.
With
more
90%
5-year
event-free
survival
(EFS),
localized
germinomas
can
managed
without
aggressive
surgery,
benefit
from
followed
whole
ventricular
irradiation
local
boost.
Bifocal
non-metastatic
entities.
cured
irradiation.
EFS
over
70%,
NGGCT
delayed
case
residual
disease,
some
form
radiotherapy.
Future
will
aim
at
decreasing
side
effects
while
preserving
high
cure
rates.
Cells,
Journal Year:
2019,
Volume and Issue:
8(12), P. 1637 - 1637
Published: Dec. 14, 2019
Liquid
biopsy-based
biomarkers,
such
as
microRNAs,
represent
valuable
tools
for
patient
management,
but
often
do
not
make
it
to
integration
in
the
clinic.
We
aim
explore
issues
impeding
this
transition,
setting
of
germ
cell
tumors,
which
novel
biomarkers
are
needed.
describe
a
model
identifying
and
validating
clinically
relevant
microRNAs
tumor
patients,
using
both
vitro,
vivo
(mouse
model)
patient-derived
data.
Initial
wide
screening
candidate
is
performed,
followed
by
targeted
profiling
potentially
biomarkers.
demonstrate
relevance
appropriate
(negative)
controls,
experimental
conditions
(proliferation),
related
sample
origin
(serum,
plasma,
cerebral
spinal
fluid)
pre-analytical
variables
(hemolysis,
contaminants,
temperature),
all
could
interfere
with
liquid
studies
their
conclusions.
Finally,
we
show
value
our
identification
specific
scenario,
contradicting
presumed
role
miR-375
marker
teratoma
histology
biopsy
setting.
Our
findings
indicate
other
putative
(miR-885-5p,
miR-448
miR-197-3p)
fulfilling
clinical
need.
The
informative
identify
best
pursue
Nature Cell Biology,
Journal Year:
2023,
Volume and Issue:
25(10), P. 1439 - 1452
Published: Sept. 14, 2023
Abstract
Germline
commitment
following
primordial
germ
cell
(PGC)
specification
during
early
human
development
establishes
an
epigenetic
programme
and
competence
for
gametogenesis.
Here
we
follow
the
progression
of
nascent
PGC-like
cells
derived
from
embryonic
stem
in
vitro.
We
show
that
switching
BMP
signalling
PGC
to
Activin
A
retinoic
acid
resulted
DMRT1
CDH5
expression,
indicators
migratory
PGCs
vivo.
Moreover,
induction
SOX17
promoted
resetting
with
striking
global
enrichment
5-hydroxymethylcytosine
locus-specific
loss
5-methylcytosine
at
binding
sites
expression
DAZL
representing
DNA
methylation-sensitive
genes,
a
hallmark
germline
programme.
provide
insight
into
unique
role
advances
biology
vitro
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2025,
Volume and Issue:
14
Published: Jan. 9, 2025
The
microbiome-gut-testis
axis
has
emerged
as
a
significant
area
of
interest
in
understanding
testicular
cancer,
particularly
germ
cell
tumors
(TGCTs),
which
represent
the
most
common
malignancy
young
men.
interplay
between
gut
and
microbiomes
is
hypothesized
to
influence
tumorigenesis
reproductive
health,
underscoring
complex
role
microbial
ecosystems
disease
pathology.
encompasses
interactions
microbiome,
systemic
immune
modulation,
local
microenvironment
testis.
Dysbiosis
or
may
contribute
altered
responses,
inflammation,
hormonal
imbalances,
potentially
playing
pathogenesis
TGCTs.
Concurrently,
seminal
have
been
linked
variations
sperm
quality,
fertility
potential,
possibly
cancer
susceptibility,
need
for
further
evaluation.
This
review
explores
emerging
context
highlighting
its
implications
onset,
progression,
treatment
efficacy,
toxicity.
Identifying
potential
biomarkers,
followed
by
microbiota
modulation
restore
balanced
community,
might
offer
novel
supportive
strategy
improving
efficacy
refractory
TGCT
patients
while
reducing
chemotherapy-induced
We
suggest
better
association
dysregulated
environments
TGCTs
emphasizes
pathways
microbiome
cancer.
Science Advances,
Journal Year:
2025,
Volume and Issue:
11(9)
Published: Feb. 26, 2025
Small
cell
carcinoma
of
the
ovary,
hypercalcemic
type
(SCCOHT)
is
a
rare
and
lethal
tumor
in
adolescent
young
adult
patients.
Now,
there
no
standard-of-care
treatment
for
these
Reliable
models
that
represent
this
disease
can
be
used
translational
research
are
scarce.
To
model
SCCOHTs,
we
have
established
eight
patient-derived
tumoroid
lines
from
lesions
three
patients
with
SCCOHT.
The
tumoroids
recapitulate
genomic
transcriptomic
characteristics
corresponding
patient
tumors
capture
intrapatient
heterogeneity.
Organoid
drug
profiling
using
library
153
clinical
compounds
identified
methotrexate
as
an
effective
selective
against
SCCOHTs
clinically
relevant
IC
50
35
nanomolars.
RNA
sequencing
demonstrated
induced
TP53
pathway
activation
apoptosis.
These
data
underscore
organoid
technology
support
design
therapeutic
strategies
cancers.